Evidence map›Paper›PMID 34851498›Full record

ArticlePharmaceutical research2021

Correlative Image-Based Release Prediction and 3D Microstructure Characterization for a Long Acting Parenteral Implant.

Zhen Liu, Li Li, Shawn Zhang, Josh Lomeo, Aiden Zhu, Jacie Chen, Stephanie Barrett, Athanas Koynov, Seth Forster, Peter Wuelfing and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Zhen LiuPreformulation Sciences, Preclinical Development, Merck & Co., Inc., Kenilworth, NJ, 07033, USA.
Li LiAnalytical Sciences, Preclinical Development, Merck & Co., Inc., Kenilworth, NJ, 07033, USA.
Shawn ZhangDigiM Solution LLC, Burlington, MA, 01803, USA. shawn.zhang@digimsolution.com.ORCID http://orcid.org/0000-0002-8068-673X
Josh LomeoDigiM Solution LLC, Burlington, MA, 01803, USA.
Aiden ZhuDigiM Solution LLC, Burlington, MA, 01803, USA.
Jacie ChenDigiM Solution LLC, Burlington, MA, 01803, USA.
Stephanie BarrettBiopharmaceutics & Specialty Dosage Forms Preclinical Development, Merck & Co., Inc., Kenilworth, NJ, 07033, USA.
Athanas KoynovBiopharmaceutics & Specialty Dosage Forms Preclinical Development, Merck & Co., Inc., Kenilworth, NJ, 07033, USA.
Seth ForsterPharm Commercialization Technology, Merck & Co., Inc., Kenilworth, NJ, 07033, USA.
Peter WuelfingDiscovery Pharmaceutical Sciences, Merck & Co., Inc., Kenilworth, NJ, 07033, USA.
Wei XuPreformulation Sciences, Preclinical Development, Merck & Co., Inc., Kenilworth, NJ, 07033, USA. wei_xu@merck.com.
Merck & Co., Inc., Rahway, NJ, USA (United States) · USAbeam Technologies (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Imaging-based characterization of polymeric drug-eluting implants can be challenging due to the microstructural complexity and scale of dispersed drug domains and polymer matrix. The typical evaluation via real-time (and accelerated in vitro experiments not only can be very labor intensive since implants are designed to last for 3 months or longer, but also fails to elucidate the impact of the internal microstructure on the implant release rate. A novel characterization technique, combining multi-scale high resolution three-dimensional imaging, was developed for a mechanistic understanding of the impact of formulation and manufacturing process on the implant microstructure. Artificial intelligence-based image segmentation and imaging analytics convert "visualized" structural properties into numerical models, which can be used to calculate key parameters governing drug transport in the polymer matrix, such as effective permeability. Simulations of drug transport in structures constructed on the basis of image analytics can be used to predict the release rates for the drug-eluting implant without running lengthy experiments. Multi-scale imaging approach and image-based characterization generate a large amount of quantitative structural information that are difficult to obtain experimentally. The direct-imaging based analytics and simulation is a powerful tool and has potential to advance fundamental understanding of drug release mechanism and the development of robust drug-eluting implants.

Indexed as

Drug LiberationDrug CompoundingDrug ImplantsImaging, Three-DimensionalMicroscopy, Electron, ScanningPolymersTomography, X-Ray ComputedDrug ImplantsPolymerscorrelative imaging characterizationdrug-eluting implantfocused ion beam scanning Electronimage-based numerical analytics and simulationmicroscopy (FIB-SEM)X-ray computed tomography (XRCT)

Identifiers

PMID34851498
OpenAlexW3217681527

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.